CFH and neoplasm: A variety of cell-based assays have demonstrated the ability of mAbs to recruit complement components in vitro, but the efficiency of CDC to kill tumor cells in vivo is less clear, particularly for solid tumors, in part because tumor cells themselves express membrane-bound complement regulators as well as the soluble regulator factor H [22,23,24].